We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.28%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.8B
AUM Growth
+$1.26B
Cap. Flow
+$567M
Cap. Flow %
3.2%
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$64.8M
2
HRL icon
Hormel Foods
HRL
+$61.4M
3
GILD icon
Gilead Sciences
GILD
+$59.9M
4
HLT icon
Hilton Worldwide
HLT
+$54.7M
5
FTI icon
TechnipFMC
FTI
+$51M

Sector Composition

Rank Sector Weight
1 Technology 14.87%
2 Healthcare 14.18%
3 Financials 11.71%
4 Industrials 10.79%
5 Consumer Discretionary 10.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICPT
1426
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$46K ﹤0.01%
282
+187
+197% +$29.5K
XL
1427
DELISTED
XL Group Ltd.
XL
$46K ﹤0.01%
1,390
BNL
1428
DELISTED
BUNZL PLC ADS (RP 5 ORD SHS)
BNL
$46K ﹤0.01%
1,586
AVAV icon
1429
AeroVironment
AVAV
$7.57B
$45K ﹤0.01%
1,871
+66
+4% +$1.77K
NNBR icon
1430
NN Inc
NNBR
$272M
$45K ﹤0.01%
2,500
XPO icon
1431
XPO
XPO
$25B
$45K ﹤0.01%
3,614
ATHX
1432
DELISTED
Athersys, Inc. Common Stock
ATHX
$45K ﹤0.01%
860
MNK
1433
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$45K ﹤0.01%
660
+28
+4% +$2.03K
SDRL
1434
DELISTED
Seadrill Limited Common Stock
SDRL
$45K ﹤0.01%
71
JPM.PRA.CL
1435
DELISTED
JPMORGAN CHASE & CO. Depositary Shares, each representing a 1/400 interest in a share of 5.45% Non-C
JPM.PRA.CL
$45K ﹤0.01%
1,700
CMT icon
1436
Core Molding Technologies
CMT
$210M
$44K ﹤0.01%
2,650
CRH icon
1437
CRH
CRH
$66.7B
$44K ﹤0.01%
1,357
-20
-1% -$633
IVOO icon
1438
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.73B
$44K ﹤0.01%
+842
New +$43.9K
TRIP icon
1439
TripAdvisor
TRIP
$1.59B
$44K ﹤0.01%
700
XLG icon
1440
Invesco S&P 500 Top 50 ETF
XLG
$10.5B
$44K ﹤0.01%
2,900
-2,000
-41% -$30.5K
MS.PRG.CL
1441
DELISTED
MORGAN STANLEY 6.625% Called for Redemption
MS.PRG.CL
$44K ﹤0.01%
1,600
HDNG
1442
DELISTED
Hardinge Inc
HDNG
$44K ﹤0.01%
4,000
SSRI
1443
DELISTED
Silver Standard Resources
SSRI
$44K ﹤0.01%
3,700
-4,000
-52% -$54K
LNKD
1444
DELISTED
LinkedIn Corporation
LNKD
$44K ﹤0.01%
232
+7
+3% +$1.34K
PRO
1445
DELISTED
PROS Holdings
PRO
$43K ﹤0.01%
1,925
-130
-6% -$2.49K
RGR icon
1446
Sturm, Ruger & Co
RGR
$610M
$43K ﹤0.01%
+750
New +$47.5K
UMBF icon
1447
UMB Financial
UMBF
$10.7B
$43K ﹤0.01%
740
EPAY
1448
DELISTED
Bottomline Technologies Inc
EPAY
$43K ﹤0.01%
1,850
+75
+4% +$1.65K
CXO
1449
DELISTED
CONCHO RESOURCES INC.
CXO
$43K ﹤0.01%
321
+29
+10% +$3.68K
AGNC icon
1450
AGNC Investment
AGNC
$12.3B
$42K ﹤0.01%
2,192

Similar funds

Glenmede Trust's Q3 2016 Portfolio in Review

As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.

  • Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
  • Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
  • Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
  • Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
  • Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
  • Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
  • Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.

Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.